US5241925A
(en)
*
|
1988-12-27 |
1993-09-07 |
Dermamed |
Apparatus and techniques for administering veterinary medicaments
|
US5332577A
(en)
*
|
1988-12-27 |
1994-07-26 |
Dermamed |
Transdermal administration to humans and animals
|
US5091186A
(en)
*
|
1989-08-15 |
1992-02-25 |
Cygnus Therapeutic Systems |
Biphasic transdermal drug delivery device
|
US5124157A
(en)
*
|
1989-08-18 |
1992-06-23 |
Cygnus Therapeutic Systems |
Method and device for administering dexmedetomidine transdermally
|
US5324521A
(en)
*
|
1989-12-18 |
1994-06-28 |
Dermamed |
Systems for transdermal administration of medicaments
|
US5152997A
(en)
*
|
1990-12-11 |
1992-10-06 |
Theratech, Inc. |
Method and device for transdermally administering testosterone across nonscrotal skin at therapeutically effective levels
|
US5246706A
(en)
*
|
1991-07-19 |
1993-09-21 |
Cygnus Therapeutic Systems |
Device for administering bimakalim transdermally
|
US5352456A
(en)
*
|
1991-10-10 |
1994-10-04 |
Cygnus Therapeutic Systems |
Device for administering drug transdermally which provides an initial pulse of drug
|
US5246705A
(en)
*
|
1992-04-08 |
1993-09-21 |
Cygnus Therapeutic System |
Occlusive, elastomeric backing materials in transdermal drug delivery systems, and associated methods of manufacture and use
|
US6673335B1
(en)
*
|
1992-07-08 |
2004-01-06 |
Nektar Therapeutics |
Compositions and methods for the pulmonary delivery of aerosolized medicaments
|
US6582728B1
(en)
*
|
1992-07-08 |
2003-06-24 |
Inhale Therapeutic Systems, Inc. |
Spray drying of macromolecules to produce inhaleable dry powders
|
US6162456A
(en)
*
|
1992-09-24 |
2000-12-19 |
Ortho-Mcneil Pharmaceutical, Inc. |
Adhesive transdermal drug delivery matrix of a physical blend of hydrophilic and hydrophobic polymers
|
DK0679088T3
(da)
*
|
1992-09-29 |
2002-10-28 |
Inhale Therapeutic Syst |
Pulmonal levering af aktive fragmenter af parathyreoideaea hormon
|
US5989586A
(en)
*
|
1992-10-05 |
1999-11-23 |
Cygnus, Inc. |
Two-phase matrix for sustained release drug delivery device
|
US5591767A
(en)
*
|
1993-01-25 |
1997-01-07 |
Pharmetrix Corporation |
Liquid reservoir transdermal patch for the administration of ketorolac
|
CA2114290C
(fr)
*
|
1993-01-27 |
2006-01-10 |
Nagabushanam Totakura |
Dispositif anti-adhesif post-chirurgical
|
US5635204A
(en)
*
|
1994-03-04 |
1997-06-03 |
Montefiore Medical Center |
Method for transdermal induction of anesthesia, analgesia or sedation
|
US20030113273A1
(en)
*
|
1996-06-17 |
2003-06-19 |
Patton John S. |
Methods and compositions for pulmonary delivery of insulin
|
KR100419037B1
(ko)
*
|
1994-03-07 |
2004-06-12 |
넥타르 테라퓨틱스 |
폐를통한인슐린의전달방법및그조성물
|
CA2190502A1
(fr)
*
|
1994-05-18 |
1995-11-23 |
Robert M. Platz |
Procedes et compositions pour produire des interferons sous forme de poudre seche
|
US6586006B2
(en)
|
1994-08-04 |
2003-07-01 |
Elan Drug Delivery Limited |
Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
|
US6290991B1
(en)
|
1994-12-02 |
2001-09-18 |
Quandrant Holdings Cambridge Limited |
Solid dose delivery vehicle and methods of making same
|
ZA964320B
(en)
*
|
1995-06-05 |
1997-01-13 |
Alza Corp |
Device for transdermal electrotransport delivery of fentanyl and sufentanil
|
FR2735024B1
(fr)
*
|
1995-06-08 |
1997-11-28 |
Sanofi Sa |
Dispositif d'administration cutanee d'un produit medicamenteux ou cosmetique.
|
US5807570A
(en)
*
|
1995-09-29 |
1998-09-15 |
Cygnus, Inc. |
Transdermal administration of ropinirole and analogs thereof
|
TW411277B
(en)
*
|
1996-05-13 |
2000-11-11 |
Hisamitsu Pharmaceutical Co |
Percutaneous tape preparation containing fentanyl
|
US5709878A
(en)
*
|
1996-08-02 |
1998-01-20 |
Rosenbaum; Jerry |
Transdermal delivery of dehydroepiandrosterone
|
US5955097A
(en)
|
1996-10-18 |
1999-09-21 |
Virotex Corporation |
Pharmaceutical preparation applicable to mucosal surfaces and body tissues
|
US5800832A
(en)
*
|
1996-10-18 |
1998-09-01 |
Virotex Corporation |
Bioerodable film for delivery of pharmaceutical compounds to mucosal surfaces
|
US5968547A
(en)
|
1997-02-24 |
1999-10-19 |
Euro-Celtique, S.A. |
Method of providing sustained analgesia with buprenorphine
|
US20030035778A1
(en)
*
|
1997-07-14 |
2003-02-20 |
Robert Platz |
Methods and compositions for the dry powder formulation of interferon
|
US6565885B1
(en)
|
1997-09-29 |
2003-05-20 |
Inhale Therapeutic Systems, Inc. |
Methods of spray drying pharmaceutical compositions
|
US20060165606A1
(en)
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
US6309623B1
(en)
*
|
1997-09-29 |
2001-10-30 |
Inhale Therapeutic Systems, Inc. |
Stabilized preparations for use in metered dose inhalers
|
US20050048102A1
(en)
*
|
1997-10-16 |
2005-03-03 |
Virotex Corporation |
Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces
|
US6352722B1
(en)
|
1997-12-23 |
2002-03-05 |
Quadrant Holdings Cambridge Limited |
Derivatized carbohydrates, compositions comprised thereof and methods of use thereof
|
US5869090A
(en)
*
|
1998-01-20 |
1999-02-09 |
Rosenbaum; Jerry |
Transdermal delivery of dehydroepiandrosterone
|
US6103266A
(en)
*
|
1998-04-22 |
2000-08-15 |
Tapolsky; Gilles H. |
Pharmaceutical gel preparation applicable to mucosal surfaces and body tissues
|
CA2367100A1
(fr)
*
|
1999-04-01 |
2000-10-12 |
Alza Corporation |
Dispositifs d'administration transdermale de medicaments comprenant un reservoir de medicament en polyurethane
|
US7179483B2
(en)
*
|
2000-04-26 |
2007-02-20 |
Watson Pharmaceuticals, Inc. |
Compositions and methods for transdermal oxybutynin therapy
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
US8404217B2
(en)
*
|
2000-05-10 |
2013-03-26 |
Novartis Ag |
Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
|
PT1280520E
(pt)
|
2000-05-10 |
2014-12-16 |
Novartis Ag |
Pós à base de fosfolípidos para administração de fármacos
|
AU2001280934A1
(en)
*
|
2000-07-28 |
2002-02-13 |
Alliance Pharmaceutical Corp. |
Methods and compositions to upregulate, redirect or limit immune responses to bioactive compounds
|
IT1318705B1
(it)
*
|
2000-09-22 |
2003-08-27 |
Gianluigi Ciocca |
Medicamento transdermico ad alta penetrazione.
|
US20020119187A1
(en)
*
|
2000-09-29 |
2002-08-29 |
Cantor Adam S. |
Composition for the transdermal delivery of fentanyl
|
US20050208117A1
(en)
*
|
2001-03-16 |
2005-09-22 |
Venkatraman Subramanian S |
Transdermal administration of fentanyl and analogs thereof
|
PL363079A1
(en)
*
|
2001-03-16 |
2004-11-15 |
Alza Corporation |
Transdermal patch for administering fentanyl
|
EP1390383B1
(fr)
*
|
2001-05-11 |
2012-02-29 |
Isis Pharmaceuticals, Inc. |
Renforcateurs de permeation antisens
|
WO2003002100A1
(fr)
*
|
2001-06-26 |
2003-01-09 |
Farrell John J |
Systeme d'administration de narcotique inviolable
|
DE10141651B4
(de)
*
|
2001-08-24 |
2007-02-15 |
Lts Lohmann Therapie-Systeme Ag |
Transdermales Therapeutisches System (TTS) mit dem Wirkstoff Fentanyl und Verfahren zu seiner Herstellung
|
US7247315B2
(en)
*
|
2001-08-17 |
2007-07-24 |
Lavipharm Laboratories Inc. |
Compositions and medical device for transdermal delivery of a drug and methods of making and using same
|
DE10141650C1
(de)
|
2001-08-24 |
2002-11-28 |
Lohmann Therapie Syst Lts |
Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
|
SI1458360T1
(sl)
|
2001-12-19 |
2011-08-31 |
Novartis Ag |
Pulmonalno dajanje aminoglikozidov
|
US20030219471A1
(en)
*
|
2002-03-11 |
2003-11-27 |
Caubel Patrick Michel |
Extended cycle estrogen and sulfatase inhibiting progestogen contraceptive regimens
|
ATE336252T1
(de)
*
|
2002-03-11 |
2006-09-15 |
Janssen Pharmaceutica Nv |
Kontinuierliche sulfatase-hemmende progestogen enthaltende hormonsubstitutions-therapie
|
JP2005519964A
(ja)
*
|
2002-03-11 |
2005-07-07 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
スルファターゼ阻害プロゲストゲンのみの避妊レジメン
|
AR033748A1
(es)
*
|
2002-05-15 |
2004-01-07 |
Thalas Group Inc |
Un dispositivo para la administracion transdermica de sustancias farmacologicamente activas que comprende dos capas adhesivas superpuestas y un procedimiento para prepararlo
|
DE10223835A1
(de)
|
2002-05-28 |
2003-12-11 |
Labtec Gmbh |
Pflaster, enthaltend Fentanylum
|
EP1509210A1
(fr)
|
2002-05-28 |
2005-03-02 |
LABTEC GESELLSCHAFT FüR TECHNOLOGISCHE FORSCHUNG UND ENTWICKLUNG MBH |
Timbre contenant du fentanyl
|
US20040086551A1
(en)
*
|
2002-10-30 |
2004-05-06 |
Miller Kenneth J. |
Fentanyl suspension-based silicone adhesive formulations and devices for transdermal delivery of fentanyl
|
DK1589955T3
(da)
*
|
2003-02-07 |
2007-03-12 |
Lohmann Therapie Syst Lts |
Transdermalt terapeutisk system til anvendelse ved varme for at fremme indtrængningen af aktive stoffer og anvendelsen deraf
|
ME00276B
(fr)
*
|
2003-04-30 |
2011-05-10 |
Purdue Pharma Lp |
Forme posologique transdermique a fermeture inviolable
|
US8790689B2
(en)
|
2003-04-30 |
2014-07-29 |
Purdue Pharma L.P. |
Tamper resistant transdermal dosage form
|
US20060200100A1
(en)
*
|
2003-06-18 |
2006-09-07 |
Rosati Coni F |
Method and apparatus for supplying gas to an area
|
US7014630B2
(en)
*
|
2003-06-18 |
2006-03-21 |
Oxyband Technologies, Inc. |
Tissue dressing having gas reservoir
|
US7816546B2
(en)
*
|
2003-06-30 |
2010-10-19 |
Richter Gedeon Vegyeszeti Gyar Rt. |
Process for the synthesis of high purity d-(17α)-13-ethyl-17-hydroxy-18,19-dinorpregn-4-ene-20-yn-3-one-oxime
|
US9205062B2
(en)
|
2004-03-09 |
2015-12-08 |
Mylan Pharmaceuticals, Inc. |
Transdermal systems containing multilayer adhesive matrices to modify drug delivery
|
US20050202073A1
(en)
|
2004-03-09 |
2005-09-15 |
Mylan Technologies, Inc. |
Transdermal systems containing multilayer adhesive matrices to modify drug delivery
|
CA2607206C
(fr)
|
2004-05-07 |
2016-06-14 |
Phytotox Limited |
Administration transdermique de phycotoxines
|
US8252319B2
(en)
|
2004-10-21 |
2012-08-28 |
Durect Corporation |
Transdermal delivery system for sufentanil
|
NZ582975A
(en)
|
2004-10-21 |
2011-07-29 |
Durect Corp |
Transdermal delivery systems delivering sufentanil
|
US20070031342A1
(en)
*
|
2005-06-22 |
2007-02-08 |
Nektar Therapeutics |
Sustained release microparticles for pulmonary delivery
|
KR100764679B1
(ko)
*
|
2005-07-22 |
2007-10-09 |
익수제약 주식회사 |
파록세틴을 함유하는 경피투여용 패취제
|
US20070098772A1
(en)
*
|
2005-09-23 |
2007-05-03 |
Westcott Tyler D |
Transdermal norelgestromin delivery system
|
US8383149B2
(en)
|
2005-09-23 |
2013-02-26 |
Alza Corporation |
High enhancer-loading polyacrylate formulation for transdermal applications
|
US20070104771A1
(en)
*
|
2005-09-23 |
2007-05-10 |
Jay Audett |
Transdermal galantamine delivery system
|
US7888422B2
(en)
*
|
2005-11-09 |
2011-02-15 |
Mylan Technologies Inc. |
Long-wearing removable pressure sensitive adhesive
|
US7955677B2
(en)
*
|
2005-12-07 |
2011-06-07 |
Mylan Technologies, Inc. |
Two-sided non-stick release film
|
US7854754B2
(en)
|
2006-02-22 |
2010-12-21 |
Zeltiq Aesthetics, Inc. |
Cooling device for removing heat from subcutaneous lipid-rich cells
|
AU2007244765A1
(en)
*
|
2006-04-28 |
2007-11-08 |
Zeltiq Aesthetics, Inc. |
Cryoprotectant for use with a treatment device for improved cooling of subcutaneous lipid-rich cells
|
US20070270925A1
(en)
*
|
2006-05-17 |
2007-11-22 |
Juniper Medical, Inc. |
Method and apparatus for non-invasively removing heat from subcutaneous lipid-rich cells including a coolant having a phase transition temperature
|
US20080004671A1
(en)
*
|
2006-06-28 |
2008-01-03 |
Alza Corporation |
Vagus nerve stimulation via orally delivered apparatus
|
US20080009782A1
(en)
*
|
2006-06-28 |
2008-01-10 |
Alza Corporation |
Methods and Devices for Transdermal Electrotransport Delivery of Lofentanil and Carfentanil
|
TW200815045A
(en)
*
|
2006-06-29 |
2008-04-01 |
Jazz Pharmaceuticals Inc |
Pharmaceutical compositions of ropinirole and methods of use thereof
|
WO2008011194A2
(fr)
|
2006-07-21 |
2008-01-24 |
Biodelivery Sciences International, Inc. |
Dispositifs d'administration transmuqueuse avec absorption accrue
|
US8192474B2
(en)
*
|
2006-09-26 |
2012-06-05 |
Zeltiq Aesthetics, Inc. |
Tissue treatment methods
|
US20080077201A1
(en)
*
|
2006-09-26 |
2008-03-27 |
Juniper Medical, Inc. |
Cooling devices with flexible sensors
|
US9132031B2
(en)
|
2006-09-26 |
2015-09-15 |
Zeltiq Aesthetics, Inc. |
Cooling device having a plurality of controllable cooling elements to provide a predetermined cooling profile
|
US8653066B2
(en)
|
2006-10-09 |
2014-02-18 |
Charleston Laboratories, Inc. |
Pharmaceutical compositions
|
JP2010508130A
(ja)
*
|
2006-10-31 |
2010-03-18 |
ゼルティック エステティックス インコーポレイテッド |
皮下高脂質細胞または皮下高脂質組織を冷却する方法およびその装置
|
US20080287839A1
(en)
|
2007-05-18 |
2008-11-20 |
Juniper Medical, Inc. |
Method of enhanced removal of heat from subcutaneous lipid-rich cells and treatment apparatus having an actuator
|
US20090018626A1
(en)
*
|
2007-07-13 |
2009-01-15 |
Juniper Medical, Inc. |
User interfaces for a system that removes heat from lipid-rich regions
|
US8523927B2
(en)
*
|
2007-07-13 |
2013-09-03 |
Zeltiq Aesthetics, Inc. |
System for treating lipid-rich regions
|
US20090018624A1
(en)
*
|
2007-07-13 |
2009-01-15 |
Juniper Medical, Inc. |
Limiting use of disposable system patient protection devices
|
US20090018625A1
(en)
*
|
2007-07-13 |
2009-01-15 |
Juniper Medical, Inc. |
Managing system temperature to remove heat from lipid-rich regions
|
US20090018627A1
(en)
*
|
2007-07-13 |
2009-01-15 |
Juniper Medical, Inc. |
Secure systems for removing heat from lipid-rich regions
|
ES2693430T3
(es)
|
2007-08-21 |
2018-12-11 |
Zeltiq Aesthetics, Inc. |
Monitorización del enfriamiento de células subcutáneas ricas en lípidos, como el enfriamiento de tejido adiposo
|
US9017301B2
(en)
*
|
2007-09-04 |
2015-04-28 |
Mylan Technologies, Inc. |
Transdermal drug delivery systems comprising a coated release liner
|
EP2207507B1
(fr)
*
|
2007-10-15 |
2018-11-21 |
Alza Corporation |
Administration transdermique à remplacement quotidien de fentanyle
|
JP5535640B2
(ja)
*
|
2007-10-17 |
2014-07-02 |
久光製薬株式会社 |
フェンタニル含有経皮吸収製剤
|
EP2240022B1
(fr)
|
2008-01-09 |
2016-12-28 |
Charleston Laboratories, Inc. |
Comprimés à deux couches contenant oxycodone et promethazine
|
WO2010036732A1
(fr)
*
|
2008-09-25 |
2010-04-01 |
Zeltiq Aesthetics, Inc. |
Systèmes et procédés de planification de traitement pour applications de remodelage corporel
|
US8603073B2
(en)
*
|
2008-12-17 |
2013-12-10 |
Zeltiq Aesthetics, Inc. |
Systems and methods with interrupt/resume capabilities for treating subcutaneous lipid-rich cells
|
WO2010127315A2
(fr)
|
2009-04-30 |
2010-11-04 |
Zeltiq Aesthetics, Inc. |
Dispositif, système et procédé d'élimination de chaleur à partir de cellules riches en lipide sous-cutanées
|
WO2011006012A1
(fr)
|
2009-07-08 |
2011-01-13 |
Charleston Laboratories Inc. |
Compositions pharmaceutiques
|
US8701671B2
(en)
|
2011-02-04 |
2014-04-22 |
Joseph E. Kovarik |
Non-surgical method and system for reducing snoring
|
US9549842B2
(en)
|
2011-02-04 |
2017-01-24 |
Joseph E. Kovarik |
Buccal bioadhesive strip and method of treating snoring and sleep apnea
|
KR20120113788A
(ko)
*
|
2010-01-25 |
2012-10-15 |
젤티크 애스세틱스, 인코포레이티드. |
상 변화 냉각제를 경유하여 피하 지질-풍부 세포로부터 열을 비침습성으로 제거하기 위한 가정용 어플리케이터 및 연관 디바이스, 시스템 및 방법
|
CN107115326B
(zh)
|
2010-04-13 |
2021-01-22 |
雷尔玛达治疗股份有限公司 |
1-甲基-n-(2,6-二甲苯基)-2-哌啶甲酰胺的皮肤用药物组合物及其使用方法
|
US11064921B2
(en)
*
|
2010-06-29 |
2021-07-20 |
Abbott Diabetes Care Inc. |
Devices, systems and methods for on-skin or on-body mounting of medical devices
|
US8676338B2
(en)
|
2010-07-20 |
2014-03-18 |
Zeltiq Aesthetics, Inc. |
Combined modality treatment systems, methods and apparatus for body contouring applications
|
US10722395B2
(en)
|
2011-01-25 |
2020-07-28 |
Zeltiq Aesthetics, Inc. |
Devices, application systems and methods with localized heat flux zones for removing heat from subcutaneous lipid-rich cells
|
US8627816B2
(en)
*
|
2011-02-28 |
2014-01-14 |
Intelliject, Inc. |
Medicament delivery device for administration of opioid antagonists including formulations for naloxone
|
US8939943B2
(en)
|
2011-01-26 |
2015-01-27 |
Kaleo, Inc. |
Medicament delivery device for administration of opioid antagonists including formulations for naloxone
|
US11951140B2
(en)
|
2011-02-04 |
2024-04-09 |
Seed Health, Inc. |
Modulation of an individual's gut microbiome to address osteoporosis and bone disease
|
US11951139B2
(en)
|
2015-11-30 |
2024-04-09 |
Seed Health, Inc. |
Method and system for reducing the likelihood of osteoporosis
|
US11844720B2
(en)
|
2011-02-04 |
2023-12-19 |
Seed Health, Inc. |
Method and system to reduce the likelihood of dental caries and halitosis
|
CA3119258A1
(fr)
|
2011-08-18 |
2013-02-21 |
Biodelivery Sciences International, Inc. |
Dispositifs mucoadhesifs anti-abus destines a administrer de la buprenorphine
|
WO2013109323A2
(fr)
*
|
2011-10-21 |
2013-07-25 |
The University Of North Carolina At Chapel Hill |
Formulations topiques de promédicament à base de dtpa et leurs procédés d'utilisation
|
US9901539B2
(en)
|
2011-12-21 |
2018-02-27 |
Biodelivery Sciences International, Inc. |
Transmucosal drug delivery devices for use in chronic pain relief
|
TW201431570A
(zh)
|
2012-11-22 |
2014-08-16 |
Ucb Pharma Gmbh |
用於經皮投服羅替戈汀(Rotigotine)之多天式貼片
|
WO2014082046A1
(fr)
|
2012-11-26 |
2014-05-30 |
The University Of North Carolina At Chapel Hill |
Esters diéthyliques de dtpa, leurs compositions et leurs procédés d'utilisation
|
US20140158572A1
(en)
*
|
2012-12-07 |
2014-06-12 |
Inventagon Llc |
Wound Care Dressing
|
WO2014105480A1
(fr)
|
2012-12-28 |
2014-07-03 |
Teikoku Pharma Usa, Inc. |
Compositions de buprénorphine à libération transdermique prolongée et leurs méthodes d'utilisation
|
US9844460B2
(en)
|
2013-03-14 |
2017-12-19 |
Zeltiq Aesthetics, Inc. |
Treatment systems with fluid mixing systems and fluid-cooled applicators and methods of using the same
|
US9545523B2
(en)
|
2013-03-14 |
2017-01-17 |
Zeltiq Aesthetics, Inc. |
Multi-modality treatment systems, methods and apparatus for altering subcutaneous lipid-rich tissue
|
BR112015032929B1
(pt)
|
2013-07-03 |
2022-08-23 |
Lts Lohmann Therapie-Systeme Ag |
Sistema terapêutico transdérmico com componente eletrônico e métodos de produção de um sistema terapêutico transdérmico
|
US11826388B2
(en)
|
2013-12-20 |
2023-11-28 |
Seed Health, Inc. |
Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation
|
US11839632B2
(en)
|
2013-12-20 |
2023-12-12 |
Seed Health, Inc. |
Topical application of CRISPR-modified bacteria to treat acne vulgaris
|
US11833177B2
(en)
|
2013-12-20 |
2023-12-05 |
Seed Health, Inc. |
Probiotic to enhance an individual's skin microbiome
|
WO2015117032A1
(fr)
|
2014-01-31 |
2015-08-06 |
Zeltiq Aesthestic, Inc. |
Systèmes de traitement permettant le traitement des glandes par refroidissement
|
US10675176B1
(en)
|
2014-03-19 |
2020-06-09 |
Zeltiq Aesthetics, Inc. |
Treatment systems, devices, and methods for cooling targeted tissue
|
USD777338S1
(en)
|
2014-03-20 |
2017-01-24 |
Zeltiq Aesthetics, Inc. |
Cryotherapy applicator for cooling tissue
|
US10952891B1
(en)
|
2014-05-13 |
2021-03-23 |
Zeltiq Aesthetics, Inc. |
Treatment systems with adjustable gap applicators and methods for cooling tissue
|
US11633367B2
(en)
|
2014-05-20 |
2023-04-25 |
Lts Lohmann Therapie-Systeme Ag |
Transdermal delivery system containing rotigotine
|
WO2015177209A1
(fr)
*
|
2014-05-20 |
2015-11-26 |
Lts Lohmann Therapie-Systeme Ag |
Méthode de régulation de libération d'agent actif dans un système d'administration transdermique
|
CA2948221C
(fr)
|
2014-05-20 |
2022-11-22 |
Lts Lohmann Therapie-Systeme Ag |
Systeme d'administration transdermique comprenant un mediateur d'interface
|
US9517307B2
(en)
|
2014-07-18 |
2016-12-13 |
Kaleo, Inc. |
Devices and methods for delivering opioid antagonists including formulations for naloxone
|
US10568759B2
(en)
|
2014-08-19 |
2020-02-25 |
Zeltiq Aesthetics, Inc. |
Treatment systems, small volume applicators, and methods for treating submental tissue
|
US10935174B2
(en)
|
2014-08-19 |
2021-03-02 |
Zeltiq Aesthetics, Inc. |
Stress relief couplings for cryotherapy apparatuses
|
WO2017070112A1
(fr)
|
2015-10-19 |
2017-04-27 |
Zeltiq Aesthetics, Inc. |
Systèmes de traitement vasculaire, dispositifs de refroidissement et procédés pour refroidir des structures vasculaires
|
CN108472151B
(zh)
|
2016-01-07 |
2020-10-27 |
斯尔替克美学股份有限公司 |
在组织冷却期间施用器与皮肤之间的温度依赖性粘附
|
US10765552B2
(en)
|
2016-02-18 |
2020-09-08 |
Zeltiq Aesthetics, Inc. |
Cooling cup applicators with contoured heads and liner assemblies
|
CA3055170A1
(fr)
|
2016-03-04 |
2017-09-08 |
Charleston Laboratories, Inc. |
Compositions pharmaceutiques
|
US10555831B2
(en)
|
2016-05-10 |
2020-02-11 |
Zeltiq Aesthetics, Inc. |
Hydrogel substances and methods of cryotherapy
|
US10682297B2
(en)
|
2016-05-10 |
2020-06-16 |
Zeltiq Aesthetics, Inc. |
Liposomes, emulsions, and methods for cryotherapy
|
US11382790B2
(en)
|
2016-05-10 |
2022-07-12 |
Zeltiq Aesthetics, Inc. |
Skin freezing systems for treating acne and skin conditions
|
US11076879B2
(en)
|
2017-04-26 |
2021-08-03 |
Zeltiq Aesthetics, Inc. |
Shallow surface cryotherapy applicators and related technology
|
CA3107932A1
(fr)
|
2018-07-31 |
2020-02-06 |
Zeltiq Aesthetics, Inc. |
Procedes, dispositifs et systemes pour l'amelioration d'une ou de plusieurs caracteristiques de la peau
|